William Sterlacci

Summary

Affiliation: Innsbruck Medical University
Country: Austria

Publications

  1. ncbi Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies
    William Sterlacci
    Department of Pathology, Medical University of Innsbruck, Muellerstr 44, Innsbruck, Austria
    Virchows Arch 452:91-5. 2008
  2. ncbi Idiopathic systemic amyloidosis primarily affecting the lungs with fatal pulmonary haemorrhage due to vascular involvement
    William Sterlacci
    Institute of Pathology, Medical University of Innsbruck, Mullerstrasse 44, 6020, Innsbruck, Austria
    Pathol Oncol Res 15:133-6. 2009
  3. ncbi Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases
    William Sterlacci
    Institute for Pathology, Medical University Innsbruck, Muellerstrasse 44, 6020 Innsbruck, Austria
    Virchows Arch 455:125-32. 2009
  4. ncbi Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact
    William Sterlacci
    Academic Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Institute for Pathology, Carinagasse 47, 6807 Feldkirch, Austria
    Am J Clin Pathol 137:946-56. 2012
  5. ncbi High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer
    William Sterlacci
    University Teaching Hospital Feldkirch, Institute for Pathology, Carinagasse 47, 6807 Feldkirch, Austria
    Hum Pathol 43:339-49. 2012
  6. ncbi A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas
    William Sterlacci
    Institute for Pathology, Academic Teaching Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Carinagasse, Feldkirch, Austria
    J Thorac Oncol 6:1649-57. 2011
  7. ncbi The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics
    William Sterlacci
    Institute for Pathology, Academic Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Feldkirch, Austria
    Am J Clin Pathol 135:611-8. 2011
  8. ncbi Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients
    William Sterlacci
    Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Institute for Pathology, Carinagasse 47, Feldkirch, Austria
    J Thorac Oncol 5:1325-36. 2010
  9. ncbi The elderly patient with surgically resected non-small cell lung cancer--a distinct situation?
    William Sterlacci
    University Teaching Hospital Feldkirch, Institute for Pathology, Carinagasse 47, 6807 Feldkirch, Austria
    Exp Gerontol 47:237-42. 2012
  10. ncbi Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer
    Andreas Pircher
    Medical University of Innsbruck, Department of Internal Medicine V Haematology and Oncology, Anichstrasse 35, A 6020 Innsbruck, Austria
    Anticancer Res 31:2949-55. 2011

Detail Information

Publications16

  1. ncbi Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies
    William Sterlacci
    Department of Pathology, Medical University of Innsbruck, Muellerstr 44, Innsbruck, Austria
    Virchows Arch 452:91-5. 2008
    ..To our knowledge, this is the second fully documented case of a thyroid follicular carcinoma-like renal tumor. This uncommon variant is important to keep in mind to prevent unnecessary or inappropriate treatment...
  2. ncbi Idiopathic systemic amyloidosis primarily affecting the lungs with fatal pulmonary haemorrhage due to vascular involvement
    William Sterlacci
    Institute of Pathology, Medical University of Innsbruck, Mullerstrasse 44, 6020, Innsbruck, Austria
    Pathol Oncol Res 15:133-6. 2009
    ..The diagnosis was established after fatal pulmonary haemorrhage caused by vessel impairment due to additional vascular amyloid deposits...
  3. ncbi Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected cases
    William Sterlacci
    Institute for Pathology, Medical University Innsbruck, Muellerstrasse 44, 6020 Innsbruck, Austria
    Virchows Arch 455:125-32. 2009
    ..In conclusion, additional immunohistochemical detection of neuroendocrine differentiation in non-small cell lung cancer is presently not of prognostic importance and does not justify a distinct consideration...
  4. ncbi Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact
    William Sterlacci
    Academic Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Institute for Pathology, Carinagasse 47, 6807 Feldkirch, Austria
    Am J Clin Pathol 137:946-56. 2012
    ..5 months; for poor differentiation, 38.5 months; P = .019). Double stains combining the aforementioned nuclear and membranous markers are highly diagnostic for NSCLC, conserving tumor tissue for subsequent analyses...
  5. ncbi High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer
    William Sterlacci
    University Teaching Hospital Feldkirch, Institute for Pathology, Carinagasse 47, 6807 Feldkirch, Austria
    Hum Pathol 43:339-49. 2012
    ..021; hazard ratio, 2.602; 95% confidence interval, 1.159-5.844). These results should help to identify patients who are most suitable for therapeutic strategies aiming to block the transforming growth factor β signaling pathway...
  6. ncbi A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas
    William Sterlacci
    Institute for Pathology, Academic Teaching Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Carinagasse, Feldkirch, Austria
    J Thorac Oncol 6:1649-57. 2011
    ..Further insight into the significance of protein expression, gene status and promoter methylation is needed and has the potential to optimize existing treatment strategies...
  7. ncbi The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics
    William Sterlacci
    Institute for Pathology, Academic Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Feldkirch, Austria
    Am J Clin Pathol 135:611-8. 2011
    ..This study elucidates sex-specific interactions between patient and tumor characteristics, which are pivotal toward improving prognostic accuracy, individualized therapies, and screening efforts...
  8. ncbi Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients
    William Sterlacci
    Hospital Feldkirch, Affiliation of the Medical University Innsbruck, Institute for Pathology, Carinagasse 47, Feldkirch, Austria
    J Thorac Oncol 5:1325-36. 2010
    ....
  9. ncbi The elderly patient with surgically resected non-small cell lung cancer--a distinct situation?
    William Sterlacci
    University Teaching Hospital Feldkirch, Institute for Pathology, Carinagasse 47, 6807 Feldkirch, Austria
    Exp Gerontol 47:237-42. 2012
    ..The Ki-67 index offers prognostic information for overall survival in the elderly...
  10. ncbi Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer
    Andreas Pircher
    Medical University of Innsbruck, Department of Internal Medicine V Haematology and Oncology, Anichstrasse 35, A 6020 Innsbruck, Austria
    Anticancer Res 31:2949-55. 2011
    ..We retrospectively analysed data for 82 patients with advanced NSCLC treated with gefitinib and correlated benefits with clinical baseline and therapy-related parameters...
  11. ncbi Absence of extramural venous invasion is an excellent predictor of metastasis-free survival in colorectal carcinoma stage II--a study using tangential tissue sectioning
    Klaus Dirschmid
    Institute for Pathology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
    J Clin Pathol 65:619-23. 2012
    ..The present prospective study applies tangential vessel preparation to CRC resection specimens and correlates results of EVI with metachronous haematogenous metastatic (MHM) spread...
  12. ncbi Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer
    William Sterlacci
    Institute of Pathology, Feldkirch Academic Hospital, Affiliation of the Innsbruck Medical University, Feldkirch, Austria
    Pathobiology 79:175-94. 2012
    ..In conclusion, the cell cycle offers several prognostic, predictive and therapeutic possibilities in NSCLC, many still developmental. Progress in this field has the potential to improve the current scenario for NSCLC patients...
  13. ncbi Splenic rupture, beyond and behind: a histological, morphometric and follow-up study of 254 cases
    William Sterlacci
    Institute of Pathology, Medical University of Innsbruck, Innsbruck, Austria
    Pathobiology 73:280-7. 2006
    ..CONCLUSIONS: Splenic rupture is due to an often unexpected underlying disease in approximately 10% of the cases. This should be kept in mind when dealing with susceptible patient groups...
  14. ncbi Angiogenesis in nodal B cell lymphomas: a high throughput study
    Alexandar Tzankov
    Institute of Pathology, Medical University of Innsbruck, Innsbruck, Austria
    J Clin Pathol 60:476-82. 2007
    ....
  15. ncbi Implications of EGFR PharmDx kit for cetuximab eligibility
    Christian Ensinger
    Institute of Pathology, Medical University of Innsbruck, A 6020 Innsbruck, Austria
    Expert Rev Mol Diagn 8:141-8. 2008
    ..This proceeding represents an important step toward a personalized cancer therapy with major advantages for patients, mainly reduction of toxic side effects and dramatically increased efficiency...
  16. ncbi Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins
    Thomas Schachner
    Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria
    Eur J Cardiothorac Surg 32:906-11. 2007
    ....